Targeted radiation weapon tested against tough bone cancer
Disease control
Recruiting now
This study is testing a new drug called LNTH-2403 for people whose osteosarcoma (a type of bone cancer) has come back or hasn't responded to standard chemotherapy. The drug is designed to deliver radiation directly to cancer cells using a special targeting system. Researchers wil…
Phase: PHASE1, PHASE2 • Sponsor: Lantheus Medical Imaging • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC